APA (7th ed.) Citation

X, B., MR, v. B., D, N., G, B., C, C., SC, D., . . . CHM, v. D. (2023). Interobserver Variation in the Assessment of Immunohistochemistry Expression Levels in HER2-Negative Breast Cancer: Can We Improve the Identification of Low Levels of HER2 Expression by Adjusting the Criteria? An International Interobserver Study. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 36(1), 100009. https://doi.org/10.1016/j.modpat.2022.100009

Chicago Style (17th ed.) Citation

X, Baez-Navarro, et al. "Interobserver Variation in the Assessment of Immunohistochemistry Expression Levels in HER2-Negative Breast Cancer: Can We Improve the Identification of Low Levels of HER2 Expression by Adjusting the Criteria? An International Interobserver Study." Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc 36, no. 1 (2023): 100009. https://doi.org/10.1016/j.modpat.2022.100009.

MLA (9th ed.) Citation

X, Baez-Navarro, et al. "Interobserver Variation in the Assessment of Immunohistochemistry Expression Levels in HER2-Negative Breast Cancer: Can We Improve the Identification of Low Levels of HER2 Expression by Adjusting the Criteria? An International Interobserver Study." Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc, vol. 36, no. 1, 2023, p. 100009, https://doi.org/10.1016/j.modpat.2022.100009.